Titre :
  • A randomised phase II trial of weekly high-dose 5-fluorouracil with and without folinic acid and cisplatin in patients with advanced biliary tract carcinoma: results of the 40955 EORTC trial.
Auteur : Ducreux, Michel ; van Cutsem, Eric ; Van Laethem, Jean-Luc ; Gress, T M ; Jeziorski, K ; Rougier, Philippe ; Wagener, Theo ; Anak, Özlem ; Baron, Benoît ; Nordlinger, Bernard ; EORTC Gastro Intestinal Tract Cancer Group
Informations sur la publication : European journal of cancer, 41, 3, (page 398-403)
Statut de publication : Publié, 2005-02
Sujet CREF : Sciences bio-médicales et agricoles
Mots-clés : 5-Fluorouracil
Biliary tract carcinoma
Cisplatin
Phase II
Survival
Toxicity
Mots-clés MeSH : Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
Biliary Tract Neoplasms -- drug therapy
Cisplatin -- administration & dosage
Disease Progression
Female
Fluorouracil -- administration & dosage
Humans
Leucovorin -- administration & dosage
Male
Middle Aged
Risk Factors
Survival Analysis
Treatment Outcome
Note : Clinical Trial
Clinical Trial, Phase II
Journal Article
Randomized Controlled Trial
Langue :
  • Anglais
Identificateurs : urn:issn:0959-8049 
info:doi/10.1016/j.ejca.2004.10.026
info:pii/S0959-8049(04)00972-4
info:pmid/15691639